23.5 C
New York
Saturday, June 13, 2026

Tag: telehealth platform

newssourceFORcompanyinformationcontent1marketreleases

ixlayer Launched Informed Pain Care, Expanding Access to Digital Acute Pain Evaluation Nationwide

Patients Can Now Connect with Licensed Clinicians through the Informed Pain Care Platform to Receive Timely Evaluation and Access to Non-Opioid Treatment Options for...

Elevate Holistics Launches Comprehensive Cannabis E-Book After Years of Consulting Patients on the Most Important Questions When It Comes to Cannabis

MORGANTOWN, W.Va., July 28, 2025 /PRNewswire/ -- "Everything You've Ever Wanted to Know About Cannabis, Finally Written Down" ...

HIMS STOCK UPDATE: Hims & Hers Health, Inc. (NYSE:HIMS) is being Sued for Securities Fraud – Contact BFA Law by August 25 Class Action...

Hims & Hers Health, Inc. investors that lost money are notified to contact BFA Law before the August 25, 2025 securities fraud class action deadline.

SkyMD Opens New Dermatology Clinic in Albuquerque, Enhancing Access to Expert Skin Care

ALBUQUERQUE, N.M., July 25, 2025 /PRNewswire/ -- SkyMD, a leading provider of innovative dermatological services, today announced the grand opening of its new clinic in Albuquerque,...

HIMS FRAUD CLASS ACTION: Hims & Hers Health, Inc. Investors may have been Affected by Fraud – Contact BFA Law by August 25 Legal...

Hims & Hers Health, Inc. investors that lost money are notified to contact BFA Law before the August 25, 2025 securities fraud class action deadline.

HIMS FRAUD ALERT: Hims & Hers Health, Inc. 34% Stock Drop Triggers Securities Fraud Class Action – Investors Notified to Contact BFA Law by...

Hims & Hers Health, Inc. investors that lost money are notified to contact BFA Law before the August 25, 2025 securities fraud class action deadline.

Remote Pharmacy Releases 2025 Availability Update on GLP-1 Weight Loss Solutions and Consumer Interest in Semaglutide & Tirzepatide

In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management options, including semaglutide and tirzepatide compounds. The release explores the evolving role of compounded therapeutics, shifts in consumer behavior toward remote prescribing, and how new formulations align with the growing interest in safe, physician-directed care for weight management. 
In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management options, including semaglutide and tirzepatide compounds. The release explores the evolving role of compounded therapeutics, shifts in consumer behavior toward remote prescribing, and how new formulations align with the growing interest in safe, physician-directed care for weight management.

22.2% CAGR, Digital Health Market Size Worth $946.04 Billion Growth, Globally, by 2030 – Exclusive Study by The Research Insights

CHICAGO, June 11, 2025 /PRNewswire/ -- The Global Digital Health Market size is projected to be valued at USD 347.35 billion in 2025 and reach USD...

NuggMD Now Serves All Eligible Medical Cannabis Patients Nationwide via Secure Telehealth Platform

Trusted Telemedicine Platform for Medical Marijuana Expands Access Across 25+ States Where Legal 
Trusted Telemedicine Platform for Medical Marijuana Expands Access Across 25+ States Where Legal

PlushCare Launches Enhanced Online Weight Loss Program to Expand National Access to GLP-1 Prescriptions Through Board-Certified Doctors

Secure Online Access to GLP-1 Weight Loss Medications Like Semaglutide Now Available Nationwide Through PlushCare’s Updated Virtual Health Platform 
Secure Online Access to GLP-1 Weight Loss Medications Like Semaglutide Now Available Nationwide Through PlushCare’s Updated Virtual Health Platform

ReflexMD Expands Digital Health Access Nationwide with Seamless Prescription Experience

Telehealth Platform Offers Nationwide Access to Licensed Providers for Weight Management, Hair Loss, and Wellness Care From Home 
Telehealth Platform Offers Nationwide Access to Licensed Providers for Weight Management, Hair Loss, and Wellness Care From Home

Dogecoin Cash Inc. (OTCQB: CBDS) Announces Symbol Change to DOGP, Planting Its Flag in the Memeosphere

MESQUITE, NV, June 10, 2025 (GLOBE NEWSWIRE) -- Dogecoin Cash Inc. (OTCQB: CBDS), a publicly traded company operating at the intersection of digital assets and public equity markets, announced today that it has received approval to change its stock ticker symbol to DOGP, effective June 10, 2025. The new symbol better aligns with the company’s identity, mission, and growing role in the decentralized meme economy.

“This move marks our territory in the memeosphere,” said David Tobias, CEO of Dogecoin Cash Inc. “DOGP isn’t just a ticker — it’s a signal that we’re serious about building in the crypto culture and our commitment to real innovation with real compliance. It signals that we’re not only part of the conversation — we’re leading the barkstorm.”

Ro Weight Loss Announces Official Website Update Featuring Natural Daily Program for Medically-Guided Weight Management

Digital health platform offers FDA-approved treatments when appropriate and personalized care plans through licensed providers. 
Digital health platform offers FDA-approved treatments when appropriate and personalized care plans through licensed providers.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsTelehealth platform

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers